Exposure of Candida parapsilosis to the silver ( I ) compound SBC3 induces alterations in the proteome and reduced virulence

Abstract

The antimicrobial properties of silver have been exploited for many centuries and continue to gain interest in the fight against an- timicrobial drug resistance. The broad-spectrum activity and low toxicity of silver have led to its incorporation into a wide range of novel antimicrobial agents, including N -heterocyclic carbene ( NHC ) complexes. The antimicrobial activity and in vivo efficacy of the NHC silver ( I ) acetate complex SBC3, derived from 1,3-dibenzyl-4,5-diphenylimidazol-2-ylidene ( NHC*) , have previously been demon- strated, although the mode ( s ) of action of SBC3 remains to be fully elucidated. Label-free quantitative proteomics was applied to analyse changes in protein abundance in the pathogenic yeast Candida parapsilosis in response to SBC3 treatment. An increased abun- dance of proteins associated with detoxification and drug efflux were indicative of a cell stress response, whilst significant decreases in proteins required for protein and amino acid biosynthesis offer potential insight into the growth-inhibitory mechanisms of SBC3. Guided by the proteomic findings and the prolific biofilm and adherence capabilities of C. parapsilosis , our studies have shown the potential of SBC3 in reducing adherence to epithelial cells and biofilm formation and hence decrease fungal virulence.